CVS Health is currently undergoing significant changes as it conducts a strategic review amidst pressure from major shareholders, particularly activist hedge fund Glenview Capital. The company is reportedly exploring various options, including a potential breakup as part of its restructuring efforts. Recent reports indicate that CVS plans to cut thousands of jobs, with around 2,900 positions being eliminated amid financial strain and investor pressure for operational improvements. As CVS's stock rises, it reflects investor optimism surrounding the upcoming talks between Glenview executives and CVS leadership, where proposals for strategic changes will be discussed. The healthcare giant is poised for a transformative period as it responds to the demands for a turnaround.